• Department of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing 210009, P.R.China;
YU Xiaojin, Email: xiaojinyu@seu.edu.cn
Export PDF Favorites Scan Get Citation

Objective To explore the application of enhanced funnel plots (EFP) and trial sequential analysis (TSA) in robustness assessment of meta-analysis results.Methods Data were extracted from published meta-analysis. The EFP was used to evaluate the robustness of the significance and heterogeneity of the current meta-analysis. The TSA was used to judge the sufficiency of the cumulative sample size of the current meta-analysis and to assess the robustness of conclusions based on current evidence.Results The EFP showed that the meta-analysis results of low-density lipoprotein (LDL) was robust, and the meta-analysis results of triglyceride (TG), total cholesterol (TC) and high-density lipoprotein (HDL) were not stable. The TSA showed that the cumulative sample size of LDL had reached the required information size (RIS), and the current conclusion was stable. The cumulative Z value of TG, TC and HDL neither reached the RIS nor passed through the TSA monitoring boundary or futility boundary, indicating that current conclusions were not robust.Conclusions The combination of EFP and TSA can make a comprehensive judgment on the robustness of current meta-analysis results, and provide methodological support in the robustness assessment of results for future systematic reviews and meta-analyses.

Citation: XIE Weihua, DAI Pinyuan, SUN Jinfang, WANG Lina, YU Xiaojin. Robustness assessment of meta-analysis results based on enhanced funnel plots and trial sequential analysis. Chinese Journal of Evidence-Based Medicine, 2020, 20(6): 713-718. doi: 10.7507/1672-2531.201910150 Copy

  • Previous Article

    Outcomes reported in clinical trials of post-stroke dysarthria: a systematic review
  • Next Article

    From guidance to practice: promoting risk communication and community engagement for prevention and control of coronavirus disease (COVID-19) outbreak in China